Gynecologic issues of the adolescent female solid organ transplant recipient

Pediatric Clinics of North America

Volumn 50, Issue 6, 2003, Pages 1521-1542

  Sucato, Gina S ^a   Murray, Pamela J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CONTRACEPTIVE AGENT; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

CHILD DEVELOPMENT; CONTRACEPTION; DIABETES MELLITUS; DIARRHEA; DRUG SAFETY; FEMALE; FEMALE GENITAL SYSTEM; HEADACHE AND FACIAL PAIN; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LIVER TRANSPLANTATION; MENSTRUAL CYCLE; OBESITY; ORGAN TRANSPLANTATION; OSTEOPOROSIS; PUBERTY; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SIDE EFFECT; VOMITING;

EID: 0345734338     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(03)00129-9     Document Type: Review

References (87)

1. de Broux E, Huot CH, Chartrand S, Vobecky S, Chartrand C. Growth and pubertal development following pediatric heart transplantation: a 15-year experience at Ste-Justine Hospital. J Heart Lung Transplant 2000;19(9):825-33.
2. Renz JF, de Roos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, et al. Posttransplantation growth in pediatric liver recipients. Liver Transplant 2001;7(12):1040-55.
3. Fine RN, Ho M, Tejani A. The contribution of renal transplantation to final adult height: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 2001;16(12):951-6.
4. Viner RM, Forton JT, Cole TJ, Clark IH, Noble-Jamieson G, Bames ND. Growth of long-term survivors of liver transplantation. Arch Dis Child 1999;180(3):235-40.
5. Fine RN, Tejani A. Growth following renal transplantation in children. Transplant Proc 1998;30(5):1959-60.
6. Diemen-Steenvoorde R, Donckerwolcke RA, Brackel H, Wolff ED, de Jong MC. Growth and sexual maturation in children after kidney transplantation. J Pediatr 1987;110(3):351-6.
7. Winkler L, Offiner G, Krull F, Brodehl J. Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 1993;152(3):244-9.
8. Bierman M, Nolan GH. Menstrual function and renal transplantation. Obstet Gynecol 1977;49(2):186-9.
9. Phocas I, Sarandakou A, Kassanos D, Rizos D, Tserkezis G, Koutsikos D. Hormonal and ultrasound characteristics of menstrual function during chronic hemodialysis and after successful renal transplantation. Int J Gynaecol Obstet 1992;37(1):19-28.
10. Ferraris JR, Domene HM, Escobar ME, Caletti MG, Ramirez JA, Rivarola MA. Hormonal profile in pubertal females with chronic renal failure: before and under haemodialysis and after renal transplantation. Acta Endocrinol (Copenh) 1987;115(3):289-96.
11. Laifer SA, Guido RS. Reproductive function and outcome of pregnancy after liver transplantation in women. Mayo Clin Proc 1995;70(4):388-94.
12. Nicholas SL, Rulin MC. Acute vaginal bleeding in women undergoing liver transplantation. Am J Obstet Gynecol 1994;170(3):733-6.
13. Blumenfeld Z, Enat R, Brandes JM, Baruch Y. Gonadotropin-releasing hormone analogues for dysfunctional bleeding in women after liver transplantation: a new application. Fertil Steril 1992;57(5):1121-3.
14. Mass K, Quint EH, Punch MR, Merion RM. Gynecological and reproductive function after liver transplantation. Transplantation 1996;62(4):476-9.
15. de Koning ND, Haagsma EB. Normalization of menstrual pattern after liver transplantation: consequences for contraception. Digestion 1990;46(4):239-41.
16. Cundy TF, O'Grady JG, Williams R. Recovery of menstruation and pregnancy after liver transplantation. Gut 1990;31(3):337-8.
17. Schroeder B, Sanfilippo JS. Dysmenorrhea and pelvic pain in adolescents. Pediatr Clin North Am 1999;46(3):555-71.
18. Bravender T, Emans SJ. Menstrual disorders: dysfunctional uterine bleeding. Pediatr Clin North Am 1999;46(3):545-53.
19. nd edition. Philadelphia: WB Saunders Company; 2001.
20. th edition. Philadelphia: Lippincott-Raven; 1998.
21. Valencia LS, Cromer BA. Sexual activity and other high-risk behaviors in adolescents with chronic illness: a review. J Pediatr Adolesc Gynecol 2000;13(2):53-64.
22. Shaben TR. Psychosocial issues in kidney-transplanted children and adolescents: literature review. ANNA J 1993;20(6):663-8.
23. Henning P, Tomlinson L, Rigden SP, Haycock GB, Chantler C. Long term outcome of treatment of end stage renal failure. Arch Dis Child 1988;63(1):35-40.
24. Suris JC, Resnick MD, Cassuto N, Blum RW. Sexual behavior of adolescents with chronic disease and disability. J Adolesc Health 1996;19(2):124-31.
25. Melzer SM, Leadbeater B, Reisman L, Jaffe LR, Lieberman KV. Characteristics of social networks in adolescents with end-stage renal disease treated with renal transplantation. J Adolesc Health Care 1989;10(4):308-12.
26. Morel P, Almond PS, Matas AJ, Gillingham KJ, Chau C, Brown A, et al. Long-term quality of life after kidney transplantation in childhood. Transplantation 1991;52(1):47-53.
27. Ghahramani N, Behzadi A, Gholami S, Salahi H, Rais-Jalali GA, Malek-Hosseini SA, et al. Postrenal transplant improvement of sexual function. Transplant Proc 1999;31(8):3144.
28. Cupples SA. Cardiac transplantation in women. Crit Care Nurs Clin North Am 1997;9(4):521-33.
29. Laifer SA, Darby MJ, Scantlebury VP, Harger JH, Caritis SN. Pregnancy and liver transplantation. Obstet Gynecol 1990;76(6):1083-8.
30. Riely CA. Contraception and pregnancy after liver transplantation. Liver Transplant 2001;7(11 Suppl 1):S74-6.
31. O'Donnell D. Contraception in the female transplant recipient. Dial Transplant 1986;15(11):610-2.
32. Kim LH, Chun CJ, Kang DM, Kwak J. Kidney transplantation and menstrual changes. Transplant Proc 1998;30:3057-9.
33. Britto MT, Rosenthal SL, Taylor J, Passo MH. Improving rheumatologists' screening for alcohol use and sexual activity. Arch Pediatr Adolesc Med 2000;154(5):478-83.
34. Smith S. Legal issues in treating minors. In: Sanfilippo J, Muram D, Dewhurst J, Lee P, editors. Pediatric and adolescent gynecology. Philadelphia: WB Saunders Company; 2001. p. 513-26.
35. Hatcher R, Guillebaud J. The pill: combined oral contraceptives. In: Hatcher R, Trussell J, Stewart F, Cates W, Stewart G, Guest F, et al, editors. Contraceptive technology. New York: Ardent Media; 1998. p. 405-66.
36. Goldzieher J. Effects on other tissues. In: Fraser I, Jansen R, Lobo R, Whitehead M, editors. Estrogens and progestogens in clinical practice. London: Churchill-Livingstone; 1998. p. 825-9.
37. Faigle J, Schenkel L. Pharmacokinetics of estrogens and progestogens. In: Fraser I, Jansen R, Lobo R, Whitehead M, editors. Estrogens and progestogens in clinical practice. London: Churchill-Livingstone; 1998. p. 273-94.
38. Longcope C. Metabolism of estrogens and progestogens. In: Fraser I, Jansen R, Lobo R, Whitehead M, editors. Estrogens and progestogens in clinical practice. London: Churchill-Livingstone; 1998. p. 89-94.
39. Kossoy LR, Herbert III CM, Wentz AC. Management of heart transplant recipients: guidelines for the obstetrician-gynecologist. Am J Obstet Gynecol 1988;159(2):490-9.
40. Creinin MD, Lisman R, Strickler RC. Screening for factor V Leiden mutation before prescribing combination oral contraceptives. Fertil Steril 1999;72(4):646-51.
41. Connell E. Clinical aspects of oral contraception. In: Fraser I, Jansen R, Lobo R, Whitehead M, editors. Estrogens and progestogens in clinical practice. London: Churchill-Livingstone; 1998. p. 555-77.
42. Deray G, Le Hoang P, Cacoub P, Assogba U, Grippon P, Baumelou A. Oral contraceptive interaction with cyclosporine. Lancet 1987;1(8525):158-9.
43. Bush WW. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. AACN Clin Issues 1999;10(2):253-69.
44. Gaston RS. Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis 2001;38(6 Suppl 6):S25-35.
45. Gustavson LE, Legler UF, Benet LZ. Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens. J Clin Endocrinol Metab 1986;62(1):234-7.
46. Seidegard J, Simonsson M, Edsbacker S. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol. Clin Pharmacol Ther 2000;67(4):373-81.
47. Munoz SJ. Long-term management of the liver transplant recipient. Med Clin North Am 1996;80(5):1103-20.
48. Cupples S. Resources for patients: transplant medications. Part 1: An overview. Prog Transplant 2002;12(1):72.
49. Dickinson BD, Altman RD, Nielsen NH, Sterling ML. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001;98(5 Pt 1):853-60.
50. Spona J, Elstein M, Feichtinger W, Sullivan H, Ludicke F, Muller U, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996;54(2):71-7.
51. Sullivan H, Fumiss H, Spona J, Elstein M. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil Steril 1999;72(1):115-20.
52. Sucato G, Gold M. Extended cycling of oral contraceptive pills for adolescents. J Pediatr Adolesc Gynecol 2002;15(5):325-7.
53. Armenti VT, Moritz MJ, Davison JM. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998;19(3):219-32.
54. Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol 2001;184(4):531-7.
55. Grimes DA, Raymond EG. Emergency contraception. Ann Intern Med 2002;137(3):180-9.
56. von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartfai G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360(9348):1803-10.
57. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998;352:428-33.
58. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002;13(5):581-7.
59. Braith RW, Howard C, Fricker FJ, Mitchell M, Edwards DG. Glucocorticoid-induced osteopenia in adolescent heart transplant recipients. J Heart Lung Transplant 2000;19(9):840-5.
60. Chesney RW, Rose PG, Mazess RB. Persistence of diminished bone mineral content following renal transplantation in childhood. Pediatrics 1984;73(4):459-66.
61. Boot AM, Nauta J, Hokken-Koelega AC, Pols HA, de Ridder MA, de Muinck Keizer-Schrama SM. Renal transplantation and osteoporosis. Arch Dis Child 1995;72(6):502-6.
62. Hatcher R. Depo-provera, norplant, and progestin-only pills (minipills). In: Hatcher R, Trussell J, Stewart F, Cates W, Stewart G, Guest F, et al, editors. Contraceptive technology. New York: Ardent Media; 1998. p. 467-510.
63. Stewart G. Intrauterine devices. In: Hatcher R, Trussell J, Stewart F, Cates W, Stewart G, Guest F, et al, editors. Contraceptive technology. New York: Ardent Media; 1998. p. 545-88.
64. Fong YF, Singh K. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient. Contraception 1999;60(1):51-3.
65. Nelson AL. The intrauterine contraceptive device. Obstet Gynecol Clin North Am 2000;27(4):723-40.
66. Damey PD. Time to pardon the IUD? N Engl J Med 2001;345(8):608-10.
67. Lee NC, Rubin GL, Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol 1988;72(1):1-6.
68. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345(8):561-7.
69. Kronmal RA, Whitney CW, Mumford SD. The intrauterine device and pelvic inflammatory disease: the Women's Health Study reanalyzed. J Clin Epidemiol 1991;44(2):109-22.
70. Zemer J, Doil KL, Drewry J, Leeber DA. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 1981;26(2):99-102.
71. Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 1999;181(5 Pt 1):1263-9.
72. Morrison CS, Sekadde-Kigondu C, Sinei SK, Weiner DH, Kwok C, Kokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women? Br J Obstet Gynaecol 2001;108(8):784-90.
73. Sinei SK, Morrison CS, Sekadde-Kigondu C, Allen M, Kokonya D. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998;351(9111):1238-41.
74. Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception 1999;60(2):57-63.
75. Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31(2): 64-72.
76. Fu H, Darroch JE, Haas T, Ranjit N. Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31(2):56-63.
77. Green M, Michaels MG. Infectious complications of solid-organ transplantation in children. Adv Pediatr Infect Dis 1992;7:181-204.
78. El Khoury J, Stikkelbroeck MM, Goodman A, Rubin RH, Cosimi AB, Fishman JA. Postmenopausal tubo-ovarian abscess due to Pseudomonas aeruginosa in a renal transplant patient: a case report and review of the literature. Transplantation 2001;72(7):1241-4.
79. Kim SW, Nah MY, Yeum CH, Kim NH, Choi HS, Juhng SW, et al. Pelvic aspergillosis with tubo-ovarian abscess in a renal transplant recipient. J Infect 2001;42(3):215-7.
80. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Available at: http://www.phppo.cdc.gov/cdcrecommends. Accessed September 6, 2003.
81. Choy BY, Peiris JS, Chan TM, Lo SK, Lui SL, Lai KN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant 2002;2(10):965-9.
82. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002;347(21):1652-61.
83. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645-51.
84. Brown MR, Noffsinger A, First MR, Penn I, Husseinzadeh N. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol 2000;79(2):220-4.
85. Sillman FH, Sentovich S, Shaffer D. Ano-genital neoplasia in renal transplant patients. Ann Transplant 1997;2(4):59-66.
86. Ozsaran AA, Ates T, Dikmen Y, Zeytinoglu A, Terek C, Erhan Y, et al. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol 1999;20(2):127-30.
87. Zeldin GA, Maygers J, Klein A, Thuluvath PJ. Vaccination, screening for malignancy, and health maintenance of the liver transplant recipient. J Clin Gastroenterol 2001;32(2):148-50.